Cytochrome P4501A1 and glutathione S transferase gene polymorphisms in patients with aplastic anemia in India

Acta Haematologica

Volumn 114, Issue 3, 2005, Pages 127-132

  Poonkuzhali, B ^a   Shaji, R V ^a   Salamun, D E ^a   George, B ^a   Srivastava, A ^a   Chandy, M ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Aplastic anemia; CYP1A1; Glutathione S transferase

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; TOXIN; XENOBIOTIC AGENT;

ADULT; ALLELE; APLASTIC ANEMIA; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; INDIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; ALLELES; ANEMIA, APLASTIC; BENZO(A)PYRENE; CASE-CONTROL STUDIES; CHILD; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 27544491740     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087885     Document Type: Article

References (34)

1. Young NS: Acquired aplastic anemia. Ann Intern Med 2002;136:534-546.
2. Young NS, Issaragrisil S, Chen WC, Takaku F: Aplastic anemia in the orient. Br J Haematol 1986;62:1-6.
3. Dameshek W: Riddle: What do aplastic anemia, PNH and hypoplastic leukemia have in common? Blood 1960;30:251-254.
4. Young NS, Alter BP: Drugs and chemicals. Aplastic anemia, acquired and inherited. Philadelphia, Saunders, 1994, pp 100-132.
5. Daly AK, Cholerton S, Armstrong M, Idle JR: Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994;102:55-61.
6. Robinson JR, Felton JS, Levitt RC, Thorgeirsson SS, Nebert DW: Relationship between aromatic hydrocarbon responsiveness and the survival times in mice treated with various drugs and environmental compounds. Mol Pharmacol 1975;11:850-865.
7. Meyer A, Nowak D, Hossfeld D, Rudiger HW: Increased formation of DNA adducts in cultured fibroblasts of patients with aplastic anemia after in vitro incubation with benzo(a)pyrene. Int Arch Occup Environ Health 1990;62:525-528.
8. Kawajiri K: CYP1A1. IARC Sci Publ 1999;148:159-172.
9. Kawajiri K, Nakachi K, Imai K, Shinoda N, Watanabe J: Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the CYP1A1 genes. FEBS Lett 1990;263:131-133.
10. Hayashi S, Watanabe J, Nakachi K, Kawajiri K: Genetic linkage of lung cancer associated MspI polymorphism with amino acid replacement in the heme binding region of the human CYP4501A1 gene. J Biochem (Tokyo) 1991;110:407-411.
11. Crofts F, Cosma GN, Currie D, Taioli E, Tonoilo P, Garte SJ: A novel CYP1A1 gene polymorphism in African Americans. Carcinogenesis 1993;14:1729-1731.
12. Cascorbi I, Brockmoeller J, Roots I: A C4887A polymorphism m exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res 1996;56:4965-4969.
13. Marsh JC, Chowdry J, Parry-Jones N, Ellis SW, Muir KR, Gordon-Smith EC, Tucker GT: Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia. Br J Haematol 1999;104:266-270.
14. Lee KA, Kim SH, Woo HY, Hong YJ, Cho HC: Increased frequencies of glutathione S-transferase (GSTM1 and GSTT1) gene deletions in Korean patients with acquired aplastic anemia. Blood 2001;98:3483-3485.
15. Sutton JF, Stacey M, Kearns WG, Rieg TS, Young NS, Liu JM: Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes. Pediatr Blood Cancer 2004;42:122-126.
16. Dirksen U, Moghadam KA, Mambetova C, Esser C, Fuhrer M, Burdach S: Glutathione S transferase theta 1 gene (GSTT1) null genotype is associated with an increased risk for acquired aplastic anemia in children. Pediatr Res 2004;55:466-471.
17. Kojima S: Aplastic anemia in the Orient. Int J Hematol 2002;76:173-174.
18. Storb R: Aplastic anaemia. J Intravenous Nurs 1987;20:317-322.
19. Yang C, Zang X: Incidence survey of aplastic anemia in China. Chin Med Sci J 1991;6:203-207.
20. Issaragrisil S, Sriratanasatavorn C, Piankijagum A, Vannasaeng S, Porapakkham Y, Leaverton PE, Kaufman DW, Anderson TE, Shapiro S, Young NS: Incidence of aplastic anemia in Bangkok. The Aplastic Anemia Study Group. Blood 1991;77:2166-2168.
21. McCahon E, Tang K, Rogers PC, McBride ML, Schultz KR: The impact of Asian descent on the incidence of acquired severe aplastic anaemia in children. Br J Haematol 2003;121:170-172.
22. Kelly JP, Jurgelon JM, Issaragrisil S, Keisu M, Kaufman DW: An epidemiological study of aplastic anaemia: Relationship of drug exposures to clinical features and outcome. Eur J Haematol Suppl 1996;60:47-52.
23. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979;53:504-514.
24. Mohanraj R, Azeez PA: Polycyclic hydrocarbons in air and their toxic potency. Resonance 2003;8:20-27.
25. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D: Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999;93:1496-1501.
26. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, Oesch F: A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 1996;36:184-186.
27. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P, Bouchardy C, Breskvar K, Brockmoller J, Cascorbi I, Clapper ML, Coutelle C, Daly A, Dell'Omo M, Dolzan V, Dresler CM, Fryer A, Haugen A, Hein DW, Hildesheim A, Hirvonen A, Hsieh LL, Ingeknan-Sundberg M, Kalina I, Kang D, Kihara M, Kiyohara C, Kremers P, Lazarus P, Le Marchand L, Lechner MC, van Lieshout EM, London S, Manni JJ, Maugard CM, Morita S, Nazar-Stewart V, Noda K, Oda Y, Pari FF, Pastorelli R, Persson I, Peters WH, Rannug A, Rebbeck T, Risch A, Roelandt L, Romkes M, Ryberg D, Salagovic J, Schoket B, Seidegard J, Shields PG, Sim E, Sinnet D, Strange RC, Stucker I, Sugimura H, To-Figueras J, Vineis P, Yu MC, Taioli E: Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 2001;10:1239-1248.
28. Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF: A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:843-854.
29. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, Gaspari L, Taioli E, Boffetta P: Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2003;12:1509-1517.
30. Wang AH, Sun CS, Li LS, Huang JY, Chen QS, Xu DZ: Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. World J Gastroenterol 2004;10:940-944.
31. Sobti RC, Sharma S, Joshi A, Jindal SK, Janmeja A: CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population. Biomarkers 2003;8:415-428.
32. Cosma G, Crofts F, Taioli E, Toniolo P, Garte S: Relationship between genotype and function of human CYP1A1 gene. J Toxicol Environ Health 1993;40:309-316.
33. Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ: Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994;15:2961-2963.
34. Vaury C, Laine R, Noguiez P, de Coppet P, Jaulin C, Praz F, Pompon D, Amor-Gueret M: Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 1995;55:5520-5523.